Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07439666 · ClinicalTrials.gov registry record · NA
NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty
A NA study, sponsored by Jacques E. Chelly.
- Not yet
- Registry status
- NA
- Development phase
- 274
- Enrollment target
NCT07439666 is a NA study that has not yet begun recruiting, run by Jacques E. Chelly. The registered enrollment target is 274 participants.
The verdict
NCT07439666, a NA study, has not yet begun recruiting, sponsored by Jacques E. Chelly.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 274 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to learn if the NEUROCUPLE device can reduce pain and opioid use after primary unilateral total knee arthroplasty (TKA) in adults. The main questions it aims to answer are: * Does the NEUROCUPLE device reduce postoperative pain at rest during the first 24 hours after TKA? * Does the NEUROCUPLE device reduce opioid consumption during the first 24 hours after TKA? Researchers will compare the NEUROCUPLE device to a placebo device (identical in appearance but inactive) to see if the device reduces pain and opioid use after surgery. Participants will: * Apply the NEUROCUPLE device or placebo device for 7 days following surgery * Have their pain and opioid use monitored through clinical records and patient reporting * Report pain at rest and during movement on postoperative Days 2 and 7 * Be assessed for nausea, vomiting, device-related side effects, length of hospital stay, and overall satisfaction
Interventions
- DEVICE NEUROCUPLE™ Patch
- DEVICE Sham patch
- OTHER Enhanced Recovery After Surgery (ERAS) Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2026-12 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07439666
The ClinicalTrials.gov registry entry for NCT07439666 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jacques E. Chelly, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which NEUROCUPLE™ Patch is the first listed.
NCT07439666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07439666 about?
NCT07439666 is a clinical study titled "NEUROCUPLE™ as an Opioid Alternative Following Total Knee Arthroplasty". The goal of this clinical trial is to learn if the NEUROCUPLE device can reduce pain and opioid use after primary unilateral total knee arthroplasty (TKA) in adults. The main questions it aims to answer are: * Does the NEUROCUPLE device reduce postoperative pain at rest during the first 24 hours a...
What is the current status of trial NCT07439666?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 274 participants. The study started on 2026-12. Estimated completion is 2027-11.
What interventions are being tested in trial NCT07439666?
The interventions under investigation include: NEUROCUPLE™ Patch (DEVICE), Sham patch (DEVICE), Enhanced Recovery After Surgery (ERAS) Standard of Care (OTHER).
Who is sponsoring clinical trial NCT07439666?
This trial is sponsored by Jacques E. Chelly, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.